Juvenile depression treatment with antidepressants from the selective serotonin reuptake inhibitors group
Suleymanov R. F., Gorenkov R. V., Chernus` N. P., Orlov S. A., Kalinina I. F.
Bangladesh Journal of Medical Science
Vol.18, Issue3, P. 615-623
Опубликовано: 2019
Тип ресурса: Статья
DOI:10.3329/bjms.v18i3.41637
Аннотация:
Objective. The article presents the juvenile depression treatment effectiveness with antidepressants of the selective serotonin reuptake inhibitors group (SSRIs). Materials and methods.182 patients were examined, including 114 men (62.6[%]) and 68 women (37.4[%]), age range 16 to 25 years, on treatment in a psycho-neurological dispensary in the city of Korolev (Russia, Moscow region) from 2014 to 2018. Results and Discussion.Main characteristics comparison of SSRIs antidepressants therapeutic effect in young men and adults of mature age revealed statistically significant age differences concerning the onset rate and these drugs antidepressant effect characteristics, as well as the adverse events nature.Conclusion. The SSRIs antidepressants clinical action regularities for depression treatment in adolescence, their therapeutic effect features and dynamics allow us to state adequate indications for the these drugs administration in adolescence, considering their age specificity. © 2019, Ibn
Ключевые слова:
Citalopram; Fluoxetine; Fluvoxamine; Juvenile depression; Paroxetine; Selective serotonin reuptake inhibitors; Sertralin; Therapy
antidepressant agent; citalopram; fluoxetine; fluvoxamine; paroxetine; serotonin uptake inhibitor; sertraline; adolescent; adolescent depression; adult; agitation; anticholinergic effect; antidepressant activity; anxiety; anxiety disorder; Article; bipolar disorder; clinical assessment; clinical feature; Clinical Global Impression scale; constipation; cyclothymia; diarrhea; disease duration; female; Hamilton Depression Rating Scale; headache; human; hypotension; ICD-10; major clinical study; male; micturition disorder; mixed anxiety and depression; monotherapy; nausea; obsession; obsessive compulsive disorder; phobia; pruritus; psychometry; psychopathy; psychosis; schizoidism; schizophrenia; side effect; sleep disorder; tachycardia; tranquilizing activity; UKU side effect rating scale; xerostomia
Язык текста: Английский
ISSN: 2223-4721
Suleymanov R. F.
Gorenkov R. V. Roman Viktorovich 1966-
Chernus` N. P. Natal`ya Pavlovna 1956-
Orlov S. A. Sergej Aleksandrovich 1987-
Kalinina I. F.
Сулеyманов Р. Ф.
Горенков Р. В. Роман Викторович 1966-
Чернусь Н. П. Наталья Павловна 1956-
Орлов С. А. Сергей Александрович 1987-
Калинина И. Ф.
Juvenile depression treatment with antidepressants from the selective serotonin reuptake inhibitors group
Текст визуальный непосредственный
Bangladesh Journal of Medical Science
Vol.18, Issue3 P. 615-623
2019
Статья
Citalopram Fluoxetine Fluvoxamine Juvenile depression Paroxetine Selective serotonin reuptake inhibitors Sertralin Therapy
antidepressant agent citalopram fluoxetine fluvoxamine paroxetine serotonin uptake inhibitor sertraline adolescent adolescent depression adult agitation anticholinergic effect antidepressant activity anxiety anxiety disorder Article bipolar disorder clinical assessment clinical feature Clinical Global Impression scale constipation cyclothymia diarrhea disease duration female Hamilton Depression Rating Scale headache human hypotension ICD-10 major clinical study male micturition disorder mixed anxiety and depression monotherapy nausea obsession obsessive compulsive disorder phobia pruritus psychometry psychopathy psychosis schizoidism schizophrenia side effect sleep disorder tachycardia tranquilizing activity UKU side effect rating scale xerostomia
Objective. The article presents the juvenile depression treatment effectiveness with antidepressants of the selective serotonin reuptake inhibitors group (SSRIs). Materials and methods.182 patients were examined, including 114 men (62.6[%]) and 68 women (37.4[%]), age range 16 to 25 years, on treatment in a psycho-neurological dispensary in the city of Korolev (Russia, Moscow region) from 2014 to 2018. Results and Discussion.Main characteristics comparison of SSRIs antidepressants therapeutic effect in young men and adults of mature age revealed statistically significant age differences concerning the onset rate and these drugs antidepressant effect characteristics, as well as the adverse events nature.Conclusion. The SSRIs antidepressants clinical action regularities for depression treatment in adolescence, their therapeutic effect features and dynamics allow us to state adequate indications for the these drugs administration in adolescence, considering their age specificity. © 2019, Ibn